Search results for "Dextran"

showing 10 items of 133 documents

CE characterization of potential toxic labile iron in colloidal parenteral iron formulations using off-capillary and on-capillary complexation with E…

2007

The present study describes the application of CZE to investigate the portion of labile iron in the following parenteral formulations: iron gluconate, iron saccharate, and iron dextran. Labile iron was detected as Fe(III)-chelate of EDTA at 246 nm. When EDTA was incubated with the formulations before electrophoresis, labile iron, or chelatable iron, respectively, was detected in all formulations, mostly in iron gluconate and iron saccharate. It was observed that the amount of iron released is time- and pH-dependent. In contrast, when EDTA was separately injected before the formulation sharp peaks of the Fe(III)-chelate were detected only after injection of iron gluconate. This type of labil…

Capillary actionChemistryIronClinical BiochemistryIron-saccharateElectrophoresis CapillaryBiochemistryGluconatesAnalytical ChemistryColloidElectrophoresisIron toxicityRehydration SolutionsIron gluconateIron dextranFluid TherapyColloidsParenteral ironEdetic AcidNuclear chemistryElectrophoresis
researchProduct

Purification and characterization of a pore-forming protein from the marine sponge Tethya lyncurium

1992

A pore-forming protein was detected and purified for the first time from a marine sponge (Tethya lyncurium). The purified protein has a polypeptide molecular mass of 21 kDa and a pI of 6.4. Tethya pore-forming protein (also called Tethya hemolysin) rapidly lysed erythrocytes from a variety of organisms. After binding to target membranes, the hemolysin resisted elution with EDTA, salt or solutions of low ionic strength and hence resembled an integral membrane protein. Erythrocytes could be protected from hemolysis induced by Tethya hemolysin by addition of 30 mM dextran 4 (4-6 kDa; equivalent hydrodynamic diffusion radius, 1.75-2.3 nm) to the extracellular medium, but not by addition of unch…

Cell Membrane PermeabilityLysisChemical PhenomenaCarbohydratesHemolysisBiochemistryPore forming proteinHemolysin ProteinsAdenosine TriphosphateOsmotic PressureAnimalsHumansColloidsIntegral membrane proteinSheepbiologyMolecular massChemistry PhysicalErythrocyte MembraneDextransHemolysinMembrane transportbiology.organism_classificationPoriferaMolecular WeightMicroscopy ElectronMembraneBiochemistryChromatography GelPotassiumTethyaRabbits
researchProduct

Release of canine parvovirus from endocytic vesicles

2003

Canine parvovirus (CPV) is a small nonenveloped virus with a single-stranded DNA genome. CPV enters cells by clathrin-mediated endocytosis and requires an acidic endosomal step for productive infection. Virion contains a potential nuclear localization signal as well as a phospholipase A(2) like domain in N-terminus of VP1. In this study we characterized the role of PLA(2) activity on CPV entry process. PLA(2) activity of CPV capsids was triggered in vitro by heat or acidic pH. PLA(2) inhibitors inhibited the viral proliferation suggesting that PLA(2) activity is needed for productive infection. The N-terminus of VP1 was exposed during the entry, suggesting that PLA(2) activity might have a …

Cell Membrane PermeabilityTransferrin receptorParvovirus CanineMembrane permeabilizationEndosomeanimal diseasesvirusesEndocytic cycleEntryBiologyEndocytosisPhospholipases AParvovirusAmiloridechemistry.chemical_compoundCapsidPhospholipase A2VirologyReceptors TransferrinmedicineAnimalsMonensinTransport VesiclesBrefeldin AVesicleBafilomycinDextransBrefeldin ALipid MetabolismEndocytosisAmilorideCell biologyEndocytic vesiclechemistryCatsCapsid ProteinsMacrolidesBafilomycin A1Lysosomesmedicine.drugVirology
researchProduct

Cladribine exerts an immunomodulatory effect on human and murine dendritic cells

2014

Cladribine is a purine nucleoside analog developed to treat lymphoid malignancies. Reported therapeutic benefits for the autoimmune disease multiple sclerosis indicate additional immunomodulatory effects beyond the well-characterized cytotoxic activity causing lymphopenia. Here, we demonstrate that cladribine reduces the secretion of inflammatory cytokines and chemokines by murine and human dendritic cells, the most potent antigen-presenting cells. This compound also modulates the expression of the activation markers CD86 and MHC II. Furthermore, cladribine affects the T cell priming capacity of dendritic cells, resulting in reduced induction of interferon-γ- and tumor necrosis factor-α-pro…

Cell SurvivalT-LymphocytesT cellImmunologyBiologyMicePhagocytosismedicineAnimalsHumansImmunologic FactorsImmunology and AllergyCytotoxic T cellAntigen-presenting cellCladribineCells CulturedCell ProliferationPharmacologyCD86ChemotaxisCell DifferentiationDextransDendritic CellsDendritic cellmedicine.diseaseMice Inbred C57BLLeukemiamedicine.anatomical_structureImmunologyLeukocytes MononuclearCancer researchCladribineCytokinesTumor necrosis factor alphaFluorescein-5-isothiocyanatemedicine.drugInternational Immunopharmacology
researchProduct

Surface Modification of Polysaccharide-Based Nanoparticles with PEG and Dextran and the Effects on Immune Cell Binding and Stimulatory Characteristic…

2017

Surface modifications of nanoparticles can alter their physical and biological properties significantly. They effect particle aggregation, circulation times, and cellular uptake. This is particularly critical for the interaction with primary immune cells due to their important role in particle processing. We can show that the introduction of a hydrophilic PEG layer on the surface of the polysaccharide-based nanoparticles prevents unwanted aggregation under physiological conditions and decreases unspecific cell uptake in different primary immune cell types. The opposite effect can be observed with a parallel-performed introduction of a layer of low molecular weight dextran (3.5 and 5 kDa) on…

Cell typeSurface PropertiesCellPrimary Cell CulturePharmaceutical Science02 engineering and technology010402 general chemistry01 natural sciencesProinflammatory cytokinePolyethylene Glycolschemistry.chemical_compoundMiceImmune systemDrug DiscoveryPEG ratiomedicineAnimalsCells CulturedChemistryMacrophagesCell MembraneDextransDendritic Cells021001 nanoscience & nanotechnology0104 chemical sciencesUp-RegulationMice Inbred C57BLDextranmedicine.anatomical_structureBiochemistryBiophysicsPEGylationMolecular MedicineSurface modificationCytokinesNanoparticles0210 nano-technologySpleenMolecular pharmaceutics
researchProduct

A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical impli…

2011

Abstract The treatment of iron deficiency anemia with polynuclear iron formulations is an established therapy in patients with chronic kidney disease but also in other disease areas like gastroenterology, cardiology, oncology, pre/post operatively and obstetrics’ and gynecology. Parenteral iron formulations represent colloidal systems in the lower nanometer size range which have traditionally been shown to consist of an iron core surrounded by a carbohydrate shell. In this publication, we for the first time describe the novel matrix structure of iron isomaltoside 1000 which differs from the traditional picture of an iron core surrounded by a carbohydrate. Despite some structural similaritie…

Chemical PhenomenaDrug CompoundingPharmaceutical ScienceIntravenous ironIron sucroseSodium ferric gluconateDisaccharidesFerric Compoundschemistry.chemical_compoundDrug Delivery SystemsIron Isomaltoside 1000medicineHumansParticle SizeInfusions IntravenousMolecular StructureHydrolysisRadiochemistryGeneral MedicineVitaminsCarbohydratemedicine.diseaseFerumoxytolMolecular WeightDextranBiochemistryIron-deficiency anemiachemistryBiotechnologymedicine.drug
researchProduct

Studies on the mechanism of PMN activation. I. By dextran sulfates.

1982

Evidence is presented that enhanced reduction of the dye nitroblue-tetrazolium (NBT) by polymorphonuclear leukocytes (PMN) which are stimulated by dextran sulfates (DS) is not exclusively due to the phagocytosis of particles formed by NBT and DS. Not only the size of phagocytizable particles but the degree of substitution determines the acceleration of NBT-reduction. A likely cause of this acceleration is the triggering of the alternative pathway of the complement activation.

ChemistryNeutrophilsPhagocytosisNitroblue TetrazoliumComplement Pathway Alternativechemical and pharmacologic phenomenaDextransHematologyGeneral MedicineComplement systemchemistry.chemical_compoundDegree of substitutionDextranBiochemistryPhagocytosisAlternative complement pathwayBiophysicsHumansBlut
researchProduct

Displacement of phenprocoumon (Marcumar) from albumin by sulfonylurea compounds, suramin, and ioglycamic acid.

1972

The technique of Sephadex gel filtration was employed to characterize the effect of some sulfonylurea compounds, ioglycamic acid, and suramin on the binding of phenprocoumon to bovine serum albumin.

ChlorpropamideChlorpropamideSuraminTolbutamideSerum albuminSuraminIn Vitro TechniquesBenzoatesPhenprocoumonCoumarinsBenzyl CompoundsmedicineAnimalsBovine serum albuminPharmacologyChromatographyBinding SitesbiologyChemistryAlbuminAnticoagulantsDextransSerum Albumin BovineGeneral MedicineCarbutamideGlycolatesCarbutamideSulfonylurea CompoundsSephadexbiology.proteinChromatography GelIodobenzoatesCattlemedicine.drugProtein BindingNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Pullulan and dextran: uncommon composition dependent Flory-Huggins interaction parameters of their aqueous solutions.

2008

Vapor pressure measurements were performed for aqueous solutions of pullulan ( M w 280 kg/mol) and dextran ( M w 60 and 2100 kg/mol, respectively) at 25, 37.5, and 50 degrees C. The Flory-Huggins interaction parameters obtained from these measurements, plus information on dilute solutions taken from the literature, show that water is a better solvent for pullulan than for dextran. Furthermore, they evince uncommon composition dependencies, including the concurrent appearance of two extrema, a minimum at moderate polymer concentration and a maximum at high polymer concentration. To model these findings, a previously established approach, subdividing the mixing process into two clearly separa…

Chromatography GasPolymers and PlasticsVapor pressureThermodynamicsBioengineeringFlory–Huggins solution theoryBiomaterialschemistry.chemical_compoundMaterials ChemistryPressureSolubilityGlucanschemistry.chemical_classificationAqueous solutionChromatographyWaterPullulanDextransPolymerSolventMolecular WeightDextranchemistryModels ChemicalSolventsThermodynamicsBiomacromolecules
researchProduct

Comparative study of Zorbax Bio Series GF 250 and GF 450 and TSK-Gel 3000 SW and SWXL columns in size-exclusion chromatography of proteins.

1988

Abstract A reduction of the mean particle diameter of silica-based packings in the size-exclusion chromatography (SEC) of proteins to about 5 μm generates the expected increase in column plate number over the traditional 10 μm SEC columns, as demonstrated for the Zorbax Bio Series GF 250 and GF 450 and TSK-Gel 3000 SWXL columns. The slightly lower column efficiency of the TSK-Gel 3000 SWXL compared with the GF 250 column is compensated by the fact that the phase ratio of the 3000 SWXL column is higher by a factor of two. Hence both columns show nearly the same peak capacity of about 20–30. When the ionic strength of the eluent was changed by varying the salt concentration, the elution volum…

ChromatographyElutionChemistryOrganic ChemistrySize-exclusion chromatographyAnalytical chemistryProteinsDextransGeneral MedicineSilicon DioxideBiochemistryAnalytical ChemistryMolecular WeightColumn chromatographyIonic strengthPhase ratioParticle diameterChromatography GelPeptidesChromatography High Pressure LiquidJournal of chromatography
researchProduct